✦ LIBER ✦

Eptifibatide did not significantly reduce the rate of adverse events in patients undergoing percutaneous coronary revascularization

✍ Scribed by Keith A.A. Fox

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Relation of hemoglobin A1c to rate of ma

✍ Roberto A Corpus; William W O'Neill; Simon R Dixon; Gerald C Timmis; William H D 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Drug-eluting stents reduce restenosis ra

✍ David F. Kong 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Safety of concomitant therapy with eptif

✍ D.L. Bhatt; B.I. Lee; P.J. Casterella 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Safety of concomitant therapy with eptif

✍ Deepak L Bhatt; Benjamin I Lee; Peter J Casterella; Mark Pulsipher; Matthew Roge 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Predictors of major adverse cardiac even

✍ Nicholas J. Ruggiero II; Stuart Gould; Heath Saltzman; Deborah DeEugenio; Abhiji 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Meta-analysis of the role of high-dose s

✍ Pan-Pan Hao; Yu-Guo Chen; Jia-Li Wang; Wen-Qing Ji; Li Xue; Xiang-Hong Liu; Xing 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB